News
In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...
A new strategy for tuberculosis (TB) screening provides a solution to problems with current TB screening, which does not always accurately detect disease. Simultaneously screening for both active and ...
1d
AllAfrica on MSNPrice of Key DR-TB Medicine Drops 25% as TB Alliance's Multi-Manufacturer Strategy Expands AccessTB Alliance's third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving affordability and accessTB Alliance applauds a new milestone in the fight ...
In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...
A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not ...
This is the latest installment of a column from John Harner, professor of geography at University of Colorado Colorado ...
In HIV, progression of illness or treatment failure is often characterized by increased HIV viral load and decreased CD4+ T-cell count. When illness progression or treatment failure occurs on ART ...
“Bimekizumab provides a much-needed treatment option for individuals struggling with this life-ruining and difficult-to-treat condition, which has very few licensed treatments.” The approval is based ...
Despite many countries offering free treatment, tuberculosis patients still face significant costs. Hospitalisation and income loss are major cost drivers, especially for drug-resistant cases.
Objectives This systematic review aimed to summarise existing literature on the impacts of armed conflicts on tuberculosis burden and treatment outcomes. Design A systematic review following the ...
Berhampur: The state govt has rolled out BPaLM, a shorter duration new treatment regimen for multi-drug resistant tuberculosis (MDR-TB) patients. The 26-week long BPaLM treatment regimen was ...
So this year they have 9 new cases with 8 existing for a total of 17 people who are going through a 6 to 9 month treatment. WHAT? THE DISEASE CAN REMAIN DORMANT FOR YEARS? Tuberculosis, or TB, is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results